American journal of ophthalmology۲۰۲۴مرور۴ استنادنمایه شده در PubMed
Andrew J Clark, Carl Regillo, Shamika Gune, Dante J Pieramici
چکیده
Most patients with retinal vascular disease require chronic, regular treatments to maximize visual potential. This places a challenging burden on the patient and is one reason why real-world visual outcomes often lag the results seen in clinical trials. Sustained drug delivery devices have long…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1016/j.ajo.2024.11.009